Elevated CRP emerges as a significant predictor of lower survival rates across various cancers, such as esophageal, colorectal, hepatocellular, pancreatic, urinary bladder, renal, ovarian, and cervical cancer, following surgical resection [7,11,12]. The gene discussed is CRP; the disease is cancer.